CAY10526

CAS No. 938069-71-7

CAY10526( CAY-10526 | CAY 10526 | BTH )

Catalog No. M27762 CAS No. 938069-71-7

CAY10526 is a selective mPGES-1 inhibitor that acts as an inhibitor of the NF-κB signaling pathway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 125 Get Quote
10MG 222 Get Quote
25MG 484 Get Quote
50MG 700 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CAY10526
  • Note
    Research use only, not for human use.
  • Brief Description
    CAY10526 is a selective mPGES-1 inhibitor that acts as an inhibitor of the NF-κB signaling pathway.
  • Description
    CAY10526 is a selective mPGES-1 inhibitor that acts as an inhibitor of the NF-κB signaling pathway.(In Vitro):CAY10526 dose-dependently inhibits PGE2 production in lipopolysaccharide-stimulated RAW 264.7 cells with an IC50 value of 1.8 μM without any effect on COX-2 expression.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CAY-10526 | CAY 10526 | BTH
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    CDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    938069-71-7
  • Formula Weight
    311.15
  • Molecular Formula
    C12H7BrO3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 66.67 mg/mL (214.27 mM)
  • SMILES
    OC1OC(=O)C(Br)=C1c1cc2ccccc2s1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tadesse S, Zhu G, Mekonnen LB, Lenjisa JL, Yu M, Brown MP, Wang S. A novel series of N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitors. Future Med Chem. 2017 Sep;9(13):1495-1506.
molnova catalog
related products
  • Dazoxiben

    Dazoxiben is a potent inhibitor of thromboxane (TX) synthase.

  • Isbogrel

    Isbogrel (CV4151) is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor that can be used to study cardiac arrhythmias, transient ischemic attacks and thrombosis.

  • Laropiprant

    A potent and selective prostaglandin D2 (PGD2) receptor (DP1) antagonist with Ki of 0.57 nM.